123 related articles for article (PubMed ID: 4837955)
21. Pituitary-thyroid function in thyrotoxic patients in relation to long-acting thyroid stimulator (LATS) levels.
Fukuchi M; Matsuoka T; Inoue T; Miyai K; Kumahara Y
Acta Endocrinol (Copenh); 1970 Dec; 65(4):577-82. PubMed ID: 5536685
[No Abstract] [Full Text] [Related]
22. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
Yamashita K; Field JB
J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
[TBL] [Abstract][Full Text] [Related]
23. [Long-acting thyroid stimulator (LATS) as the cause of hyperthyroidism. Comparison of different TSH and LATS preparations].
Seif F
Dtsch Med Wochenschr; 1967 Jan; 92(4):147-52. PubMed ID: 6016320
[No Abstract] [Full Text] [Related]
24. Relation between thyroid function and serum levels of long-acting thyroid stimulator.
Davis JC; Hipkin LJ; Summers VK; Gimlette TM
Acta Endocrinol (Copenh); 1975 Jul; 79(3):451-8. PubMed ID: 1173501
[TBL] [Abstract][Full Text] [Related]
25. Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin.
Adams DD; Kennedy TH; Stewart JC; Utiger RD; Vidor GI
J Clin Endocrinol Metab; 1975 Aug; 41(2):221-8. PubMed ID: 51028
[TBL] [Abstract][Full Text] [Related]
26. Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates.
Mehdi SQ; Badger J; Kriss JP
Endocrinology; 1977 Jul; 101(1):59-65. PubMed ID: 193685
[TBL] [Abstract][Full Text] [Related]
27. An in vitro procedure for the estimation of thyroid hormone releasing factors in sera of thyrotoxic patients.
Maayan ML; Volpert EM; Dawry FP
J Endocrinol Invest; 1978 Oct; 1(4):299-304. PubMed ID: 92490
[TBL] [Abstract][Full Text] [Related]
28. Unusual thyroid-stimulating activity in the plasma of a man with choriocarcinoma.
Winland R; Bates R; Becker CE; Rosen SW
J Clin Endocrinol Metab; 1969 Oct; 29(10):1369-72. PubMed ID: 4187630
[No Abstract] [Full Text] [Related]
29. [Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].
Földes J; Gesztesi E; Takács I
Orv Hetil; 1970 Dec; 111(52):3067-70. PubMed ID: 4099957
[No Abstract] [Full Text] [Related]
30. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
Lepp A; Oliner L
Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
[No Abstract] [Full Text] [Related]
31. Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.
Holmes SD; Dirmikis SM; Martin TJ; Munro DS
J Endocrinol; 1979 Feb; 80(2):215-21. PubMed ID: 220366
[TBL] [Abstract][Full Text] [Related]
32. Reversal of the inhibition of TSH secretion due to acute stress.
Ducommun P; Vale W; Sakiz E; Guillemin R
Endocrinology; 1967 May; 80(5):953-6. PubMed ID: 6023562
[No Abstract] [Full Text] [Related]
33. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum].
Muramoto E; Nicolau W; Ikeda E; de Assis LM; Pieroni RR
AMB Rev Assoc Med Bras; 1972 Oct; 18(10):379-88. PubMed ID: 4539360
[No Abstract] [Full Text] [Related]
34. [Simultaneous determination of thyrotropic hormone and long-acting thyroid stimulator in the plasma of patients with Graves' disease].
Földes J; Gesztesi E; Takács I
Klin Wochenschr; 1971 May; 49(9):554-7. PubMed ID: 4102376
[No Abstract] [Full Text] [Related]
35. Long-acting thyroid stimulator in Graves' disease.
Sellers EA; Awad AG; Schönbaum E
Lancet; 1970 Aug; 2(7668):335-8. PubMed ID: 4194442
[No Abstract] [Full Text] [Related]
36. Effects of human thyroid-stimulating hormone and immunoglobulins on adenylate cyclase activity and the accumulation of cyclic AMP in human thyroid membranes and slices.
Holmes SD; Dirmikis SM; Martin TJ; Munro DS
J Endocrinol; 1978 Oct; 79(1):121-30. PubMed ID: 213523
[TBL] [Abstract][Full Text] [Related]
37. Lack of response to TSH injections in euthyroid patients with high LATS levels.
Adams DD; Couchman K; Kilpatrick JA
J Clin Endocrinol Metab; 1969 Nov; 29(11):1502-3. PubMed ID: 5349725
[No Abstract] [Full Text] [Related]
38. [Inactivation of the thyroid-stimulating and exophthalmogenic effect of TSH, LATS, EPF, thyroid antibodies and serum protein fractions by iodine].
Schemmel K; Streich D; Kreysing G; Leybold K; Weisbecker L
Klin Wochenschr; 1969 Aug; 47(16):879-83. PubMed ID: 5393915
[No Abstract] [Full Text] [Related]
39. Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.
Sawhney RC; Kannan V; Rastogi GK
J Assoc Physicians India; 1975 Feb; 23(2):111-4. PubMed ID: 1242389
[No Abstract] [Full Text] [Related]
40. A radio-ligand receptor assay for the long-acting thyroid stimulator. Inhibition by the long-acting thyroid stimulator of the binding of radioiodinated thyroid-stimulating hormone to human thyroid membranes.
Mehdi SQ; Nussey SS
Biochem J; 1975 Jan; 145(1):105-11. PubMed ID: 1191248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
